LOGITECH INTERNATIONAL S.A., 10-Q filed on 1/28/2026
Quarterly Report
v3.25.4
Cover Page - shares
 9 Months Ended
Dec. 31, 2025
Jan. 14, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2025  
Document Transition Report false  
Entity File Number 0-29174  
Entity Registrant Name LOGITECH INTERNATIONAL S.A.  
Entity Incorporation, State or Country Code V8  
Entity Address, Address Line One 1015 Lausanne  
Entity Address, Country CH  
Entity Address, Address Line Two c/o Logitech Inc.  
Entity Address, Address Line Three 3930 North First Street  
Entity Address, City or Town San Jose  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95134  
City Area Code 510)  
Local Phone Number 795-8500  
Title of 12(b) Security Registered Shares  
Trading Symbol LOGI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   146,588,946
Entity Central Index Key 0001032975  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Net sales $ 1,421,479 $ 1,340,294 $ 3,755,238 $ 3,544,545
Cost of goods sold 805,267 763,403 2,141,277 2,010,411
Amortization of intangible assets 1,573 2,450 5,904 7,344
Gross profit 614,639 574,441 1,608,057 1,526,790
Operating expenses:        
Marketing and selling 206,875 217,048 601,664 615,816
Research and development 78,452 77,973 229,149 229,485
General and administrative 41,921 42,117 125,520 123,748
Amortization of intangible assets and acquisition-related costs 915 2,637 5,379 8,065
Restructuring charges, net 462 110 6,946 725
Total operating expenses 328,625 339,885 968,658 977,839
Operating income 286,014 234,556 639,399 548,951
Interest income 10,985 12,176 34,042 42,603
Other income (expense), net 2,131 (1,524) 3,229 (2,889)
Income before income taxes 299,130 245,208 676,670 588,665
Provision for income taxes 48,091 45,061 108,946 101,202
Net income $ 251,039 $ 200,147 $ 567,724 $ 487,463
Net income per share:        
Basic (in dollars per share) $ 1.71 $ 1.33 $ 3.86 $ 3.20
Diluted (in dollars per share) $ 1.69 $ 1.32 $ 3.82 $ 3.18
Weighted average shares used to compute net income per share:        
Basic (in shares) 146,827 150,647 147,265 152,127
Diluted (in shares) 148,450 151,895 148,635 153,506
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Statement of Comprehensive Income [Abstract]        
Net income $ 251,039 $ 200,147 $ 567,724 $ 487,463
Currency translation gain (loss):        
Currency translation gain (loss), net of taxes 2,269 (39,568) 26,874 (23,998)
Defined benefit plans:        
Reclassification of amortization included in other income (expense), net (181) 251 (531) (501)
Hedging gain (loss):        
Deferred hedging gain (loss), net of taxes (5,047) 3,577 (16,807) 2,228
Reclassification of hedging loss (gain) included in cost of goods sold 3,328 790 11,291 (849)
Total other comprehensive income (loss) 369 (34,950) 20,827 (23,120)
Total comprehensive income $ 251,408 $ 165,197 $ 588,551 $ 464,343
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS
$ in Thousands, SFr in Millions
Dec. 31, 2025
USD ($)
Mar. 31, 2025
USD ($)
Current assets:    
Cash and cash equivalents $ 1,817,820 $ 1,503,205
Accounts receivable, net 683,126 454,546
Inventories 449,544 503,747
Other current assets 166,988 131,211
Total current assets 3,117,478 2,592,709
Non-current assets:    
Property, plant and equipment, net 115,363 113,858
Goodwill 466,579 463,230
Other intangible assets, net 13,889 24,630
Other assets 382,380 344,077
Total assets 4,095,689 3,538,504
Current liabilities:    
Accounts payable 590,421 414,586
Accrued and other current liabilities 817,924 686,503
Total current liabilities 1,408,345 1,101,089
Non-current liabilities:    
Income taxes payable 113,621 88,483
Other non-current liabilities 238,000 221,512
Total liabilities 1,759,966 1,411,084
Commitments and contingencies (Note 10)
Shareholders’ equity:    
Registered shares, CHF 0.25 par value Issued shares: 160,784 and 168,994 at December 31, 2025 and March 31, 2025, respectively 28,001 29,432
Additional paid-in capital 104,310 82,591
Shares in treasury, at cost Treasury shares: 14,027 and 20,485 at December 31, 2025 and March 31, 2025, respectively (908,278) (1,464,912)
Retained earnings 3,237,815 3,627,261
Accumulated other comprehensive loss (126,125) (146,952)
Total shareholders’ equity 2,335,723 2,127,420
Total liabilities and shareholders’ equity $ 4,095,689 $ 3,538,504
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - SFr / shares
Dec. 31, 2025
Mar. 31, 2025
Statement of Financial Position [Abstract]    
Shares, par value (in CHF per share) SFr 0.25 SFr 0.25
Shares issued (in shares) 160,784,460 168,994,000
Treasury, at cost, shares (in shares) 14,026,614 20,485,000
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net income $ 567,724 $ 487,463
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 47,622 44,178
Amortization of intangible assets 11,283 15,258
Loss on investments 291 1,718
Share-based compensation expense 86,575 76,067
Deferred income taxes 6,296 18,652
Other 65 130
Changes in assets and liabilities:    
Accounts receivable, net (213,815) (127,934)
Inventories 66,921 (67,554)
Other assets (30,423) 9,416
Accounts payable 171,967 136,848
Accrued and other liabilities 119,908 118,659
Net cash provided by operating activities 834,414 712,901
Cash flows from investing activities:    
Purchases of property, plant and equipment (47,723) (43,340)
Purchases of deferred compensation investments (5,557) (5,802)
Proceeds from sales of deferred compensation investments 5,718 4,958
Other investing activities (1,196) (1,173)
Net cash used in investing activities (48,758) (45,357)
Cash flows from financing activities:    
Payment of cash dividends (233,059) (207,853)
Purchases of registered shares (255,380) (463,322)
Proceeds from exercises of stock options and purchase rights 24,172 20,235
Tax withholdings related to net share settlements of restricted stock units (19,406) (22,251)
Other financing activities 0 (2,908)
Net cash used in financing activities (483,673) (676,099)
Effect of exchange rate changes on cash and cash equivalents 12,632 (9,455)
Net increase (decrease) in cash and cash equivalents 314,615 (18,010)
Cash and cash equivalents, beginning of the period 1,503,205 1,520,842
Cash and cash equivalents, end of the period 1,817,820 1,502,832
Non-cash investing and financing activities:    
Property, plant and equipment purchased during the period and included in period end liability accounts 9,344 5,770
Right-of-use assets obtained in exchange for operating lease liabilities 5,967 26,564
Supplemental cash flow information:    
Income taxes paid, net $ 64,762 $ 32,586
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning of the period (in shares) at Mar. 31, 2024   173,106,000        
Beginning of the period at Mar. 31, 2024 $ 2,233,653 $ 30,148 $ 63,524 $ (1,351,336) $ 3,602,519 $ (111,202)
Beginning of the period (in shares) at Mar. 31, 2024       19,243,000    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 464,343       487,463 (23,120)
Purchases of registered shares (in shares)       5,328,000    
Purchases of registered shares (461,402)     $ (461,402)    
Sales of shares upon exercise of stock options and purchase rights 20,235   (6,065) $ 29,567 (3,267)  
Sales of shares upon exercise of stock options and purchase rights (in shares)       (273,000)    
Issuance of shares upon vesting of restricted stock units (22,251)   (38,518) $ 69,134 (52,867)  
Issuance of shares upon vesting of restricted stock units (in shares)       (631,000)    
Cancellation of treasury shares (in shares)   (4,112,000)   (4,112,000)    
Cancellation of treasury shares 0 $ (716)   $ 332,088 (331,372)  
Share-based compensation 76,221   76,221      
Cash dividends (207,981)       (207,981)  
End of the period (in shares) at Dec. 31, 2024   168,994,000        
End of the period at Dec. 31, 2024 2,102,818 $ 29,432 95,162 $ (1,381,949) 3,494,495 (134,322)
End of the period (in shares) at Dec. 31, 2024       19,555,000    
Beginning of the period (in shares) at Sep. 30, 2024   173,106,000        
Beginning of the period at Sep. 30, 2024 2,111,894 $ 30,148 72,268 $ (1,518,149) 3,626,999 (99,372)
Beginning of the period (in shares) at Sep. 30, 2024       21,270,000    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 165,197       200,147 (34,950)
Purchases of registered shares (in shares)       2,428,000    
Purchases of registered shares (199,283)     $ (199,283)    
Issuance of shares upon vesting of restricted stock units (1,008)   (3,124) $ 3,395 (1,279)  
Issuance of shares upon vesting of restricted stock units (in shares)       (31,000)    
Cancellation of treasury shares (in shares)   (4,112,000)   (4,112,000)    
Cancellation of treasury shares 0 $ (716)   $ 332,088 (331,372)  
Share-based compensation 26,018   26,018      
End of the period (in shares) at Dec. 31, 2024   168,994,000        
End of the period at Dec. 31, 2024 2,102,818 $ 29,432 95,162 $ (1,381,949) 3,494,495 (134,322)
End of the period (in shares) at Dec. 31, 2024       19,555,000    
Beginning of the period (in shares) at Mar. 31, 2025   168,994,000        
Beginning of the period at Mar. 31, 2025 $ 2,127,420 $ 29,432 82,591 $ (1,464,912) 3,627,261 (146,952)
Beginning of the period (in shares) at Mar. 31, 2025 20,485,000     20,485,000    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income $ 588,551       567,724 20,827
Purchases of registered shares (in shares)       2,678,000    
Purchases of registered shares (239,056)     $ (239,056)    
Sales of shares upon exercise of stock options and purchase rights 24,172   (3,820) $ 27,992    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (317,000)    
Issuance of shares upon vesting of restricted stock units (19,406)   (61,232) $ 55,533 (13,707)  
Issuance of shares upon vesting of restricted stock units (in shares)       (609,000)    
Cancellation of treasury shares (in shares)   (8,210,000)   (8,210,000)    
Cancellation of treasury shares 0 $ (1,431)   $ 712,165 (710,734)  
Share-based compensation 86,771   86,771      
Cash dividends (232,729)       (232,729)  
End of the period (in shares) at Dec. 31, 2025   160,784,000        
End of the period at Dec. 31, 2025 $ 2,335,723 $ 28,001 104,310 $ (908,278) 3,237,815 (126,125)
End of the period (in shares) at Dec. 31, 2025 14,026,614     14,027,000    
Beginning of the period (in shares) at Sep. 30, 2025   160,784,000        
Beginning of the period at Sep. 30, 2025 $ 2,083,013 $ 28,001 85,347 $ (890,617) 2,986,776 (126,494)
Beginning of the period (in shares) at Sep. 30, 2025       13,889,000    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 251,408       251,039 369
Purchases of registered shares (in shares)       207,000    
Purchases of registered shares (23,254)     $ (23,254)    
Sales of shares upon exercise of stock options and purchase rights 2,459   (1,028) $ 3,487    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (43,000)    
Issuance of shares upon vesting of restricted stock units (1,195)   (3,301) $ 2,106    
Issuance of shares upon vesting of restricted stock units (in shares)       (26,000)    
Share-based compensation 23,292   23,292      
End of the period (in shares) at Dec. 31, 2025   160,784,000        
End of the period at Dec. 31, 2025 $ 2,335,723 $ 28,001 $ 104,310 $ (908,278) $ 3,237,815 $ (126,125)
End of the period (in shares) at Dec. 31, 2025 14,026,614     14,027,000    
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)
 9 Months Ended
Dec. 31, 2025
$ / shares
Dec. 31, 2025
SFr / shares
Dec. 31, 2024
$ / shares
Dec. 31, 2024
SFr / shares
Statement of Stockholders' Equity [Abstract]        
Cash dividends per share (in dollars per share) | (per share) $ 1.58 SFr 1.26 $ 1.37 SFr 1.16
v3.25.4
The Company and Summary of Significant Accounting Policies and Estimates
 9 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
The Company and Summary of Significant Accounting Policies and Estimates The Company and Summary of Significant Accounting Policies and Estimates
The Company

Logitech International S.A., together with its consolidated subsidiaries ("Logitech" or the "Company"), designs software-enabled hardware solutions that help businesses thrive and bring people together when working, creating, and gaming. As the point of connection between people and the digital world, the Company's mission is to extend human potential in work and play, in a way that is good for people and the planet.

The Company sells its products to a broad range of international customers, including direct sales to retailers, e-tailers, businesses large and small and end consumers through the Company's e-commerce platform, and indirect sales to end customers through distributors.

Logitech was founded in Switzerland in 1981 and Logitech International S.A. has been the parent holding company of Logitech since 1988. Logitech International S.A. is a Swiss holding company with its registered office in Hautemorges, Switzerland, and headquarters in Lausanne, Switzerland, which conducts its business through subsidiaries in the Americas; Europe, the Middle East and Africa ("EMEA"); and Asia Pacific. Shares of Logitech International S.A. are listed on both the SIX Swiss Exchange under the trading symbol LOGN and the Nasdaq Global Select Market under the trading symbol LOGI.

Basis of Presentation

The condensed consolidated financial statements include the accounts of Logitech and its subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and therefore do not include all the information required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 23, 2025.

In the opinion of management, these condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary and in all material aspects, for a fair statement of the results of operations, comprehensive income, financial position, cash flows and changes in shareholders' equity for the periods presented. Operating results for the three and nine months ended December 31, 2025 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2026, or any future periods.

Changes in Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies during the three and nine months ended December 31, 2025 compared with the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Significant estimates and assumptions made by management involve the fair value of goodwill and intangible assets acquired from business acquisitions, pension obligations, accruals for customer incentives, cooperative marketing, and pricing programs and related breakage when appropriate, inventory valuation, share-based compensation expense, uncertain tax positions, and valuation allowances for deferred tax assets. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results could differ materially from those estimates.
 
Risks and Uncertainties

Impacts of Macroeconomic, Geopolitical, and Other Factors on the Company's Business

In 2025, the United States introduced trade policy actions that have increased import tariffs across a wide range of countries at various rates, with certain exemptions. These tariff policies in the U.S. and responsive policies enacted in other countries are evolving. The incremental tariffs have had and may continue to have an adverse impact on the Company's results of operations. The Company may also be affected by the increases in demand for memory chips and other components caused by the build out of new AI technologies and data centers, leading to a rise in prices for such components and suppliers transitioning away from supplying certain components utilized in the manufacturing of some of the Company’s Video Collaboration products. In addition, the Company's business has continued to be impacted by ongoing macroeconomic and geopolitical conditions. These conditions include inflation, interest rate and foreign currency fluctuations, uncertainty in consumer and enterprise demand, low economic growth in certain regions, changes in fiscal policies and geopolitical conflicts.

The global and regional macroeconomic and political conditions, as well as changes in trade policies and memory supply, have caused and may continue to cause volatility in demand for the Company's products, component availability, transit times, and cost of the Company's products including cost of tariffs, materials, and logistics, and as a result, have impacted and may continue to impact the pricing of the Company's products, product availability and the Company's results of operations.

New Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires additional disclosures related to rate reconciliation, income taxes paid, and other disclosures. Under ASU 2023-09, for each annual period presented, public entities are required to (1) disclose specific categories in the tabular rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. In addition, ASU 2023-09 requires all reporting entities to disclose on an annual basis the amount of income taxes paid disaggregated by federal, state, and foreign taxes as well as the amount of income taxes paid by individual jurisdiction. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 and can be applied on a prospective basis with an option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2023-09 on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. ASU 2024-03 requires all public entities to disclose in the notes to the financial statements the amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption of the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. ASU 2024-03 can be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2024-03 on its consolidated financial statements and related disclosures.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. ASU 2025-05 provides a practical expedient that permits entities to assume that current conditions as of the balance sheet date will remain unchanged over the remaining life of current accounts receivable and current contract assets when estimating the expected credit losses. ASU 2025-05 is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted. ASU 2025-05 should be applied on a prospective basis. The Company is currently evaluating the impact of ASU 2025-05 on its consolidated financial statements and related disclosures.
In September 2025, the FASB issued ASU No. 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 updates the cost capitalization threshold for internal-use software development costs by removing all references to software project development stages and providing new guidance on how to evaluate whether the probable-to-complete recognition threshold has been met. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted. ASU 2025-06 can be applied on a prospective basis, with retrospective or modified retrospective application permitted. The Company is currently evaluating the impact of ASU 2025-06 on its consolidated financial statements and related disclosures.
v3.25.4
Net Income Per Share
 9 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
 
The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2025 and 2024 (in thousands, except per share amounts):
Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Net income$251,039 $200,147 $567,724 $487,463 
Shares used in net income per share computation:    
Weighted average shares outstanding - basic146,827 150,647 147,265 152,127 
Effect of potentially dilutive equivalent shares1,623 1,248 1,370 1,379 
Weighted average shares outstanding - diluted148,450 151,895 148,635 153,506 
Net income per share:    
Basic$1.71 $1.33 $3.86 $3.20 
Diluted$1.69 $1.32 $3.82 $3.18 
 
Share equivalents attributable to outstanding stock options, restricted stock units and employee share purchase plans totaling 0.6 million and 0.9 million for the nine months ended December 31, 2025 and 2024, respectively, were excluded from the calculation of diluted net income per share because their effect would have been antidilutive. Antidilutive share equivalents totaled 0.8 million for the three months ended December 31, 2024 and were not material for the three months ended December 31, 2025. A small number of performance-based restricted stock units were not included in the diluted net income per share calculation because all necessary conditions had not been satisfied by the end of the respective period, and those shares were not issuable if the end of the reporting period were the end of the performance contingency period.
v3.25.4
Employee Benefit Plans
 9 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Employee Benefit Plans Employee Benefit Plans
 
Employee Share Purchase Plans and Stock Incentive Plans
 
As of December 31, 2025, the Company offers the 2006 Employee Share Purchase Plan (Non-U.S.), as amended and restated, the 1996 Employee Share Purchase Plan (U.S.), as amended and restated, and the 2006 Stock Incentive Plan, as amended and restated. Shares issued to employees as a result of purchases or exercises under these plans are generally issued from shares held in treasury stock.
The following table summarizes share-based compensation expense and total income tax benefit recognized for the three and nine months ended December 31, 2025 and 2024 (in thousands):
Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Cost of goods sold$2,636 $2,173 $8,375 $8,673 
Marketing and selling5,911 11,813 31,982 34,133 
Research and development5,395 5,043 17,412 15,849 
General and administrative9,493 7,164 28,806 17,412 
Total share-based compensation expense23,435 26,193 86,575 76,067 
Income tax benefit(4,699)(4,523)(15,620)(16,901)
Total share-based compensation expense, net of income tax benefit$18,736 $21,670 $70,955 $59,166 

The income tax benefit in the respective periods primarily consisted of tax benefits related to the share-based compensation expense for the period and direct tax benefit realized, including net excess tax benefits recognized from share-based awards vested or exercised during the period.

Share-based compensation costs capitalized as part of inventory were $1.9 million and $1.6 million for the three months ended December 31, 2025 and 2024, respectively, and $6.7 million and $5.9 million for the nine months ended December 31, 2025 and 2024, respectively.

Defined Benefit Plans
 
Certain subsidiaries of the Company sponsor defined benefit pension plans or non-retirement post-employment benefits covering substantially all of their employees. Benefits are provided based on employees’ years of service and earnings, or in accordance with applicable employee benefit regulations. The Company’s practice is to fund amounts sufficient to meet the requirements set forth in the applicable employee benefit and tax regulations. The costs of $1.7 million and $1.8 million recorded for the three months ended December 31, 2025 and 2024, respectively, and $5.2 million and $5.3 million recorded for the nine months ended December 31, 2025 and 2024, respectively, were primarily related to service costs.
v3.25.4
Income Taxes
 9 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
 
The Company is incorporated in Switzerland but operates in various countries with differing tax laws and rates. Further, a portion of the Company’s income before taxes and the provision for income taxes is generated outside of Switzerland.

The income tax provision for the three and nine months ended December 31, 2025 was $48.1 million and $108.9 million, respectively, based on an effective income tax rate of 16.1% of pre-tax income for both periods. The income tax provision for the same periods ended December 31, 2024 was $45.1 million and $101.2 million based on an effective income tax rate of 18.4% and 17.2% of pre-tax income, respectively.

The change in the effective income tax rate for the three and nine months ended December 31, 2025, compared with the same periods ended December 31, 2024, was primarily due to the change in the mix of income and losses in the various tax jurisdictions in which the Company operates and favorable return to provision adjustments.

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was enacted into law in the United States and will be generally effective for the Company beginning in fiscal year 2027. The OBBBA includes numerous provisions that affect corporate taxation, impacting areas such as R&D expensing, bonus depreciation, and international tax provisions. The Company has reviewed the provisions of the OBBBA to determine the potential impact on the Company's financial statements. Based on this review, and considering the Company's current tax position and operations, at this time the Company does not expect the OBBBA to have a material impact on its income taxes, including current and deferred tax balances and the effective tax rate. However, the Company is still in the process of evaluating the full impact of the OBBBA and any material changes to the Company's assessment will be disclosed in future filings as required.
For the three months ended December 31, 2025, the Company assessed its exposure to the OECD Pillar Two global minimum tax rules. The Company has determined that, for the fiscal year 2026, most jurisdictions in which it operates should qualify for the transitional Country-by-Country Reporting ("CbCR") safe harbor, as outlined in the OECD Administrative Guidance and enacted domestic legislation. The Company's CbCR has been prepared in accordance with the requirements for a Qualified CbCR, using qualified financial statements. Based on this data, most jurisdictions continue to meet safe harbor qualifications at 16% tax rates, and therefore, the Company is only required to perform a detailed Pillar Two top-up tax calculation for limited jurisdictions. The estimated top up tax for fiscal year 2026 is not material and has been included in the calculation of the Company's annual effective tax rate.

On January 5, 2026, the OECD released an Administrative Guidance package. This package includes a “Side-by-Side” System designed to align the U.S. tax regime with Pillar Two for U.S.-parented multinational groups, effective for tax years beginning on or after January 1, 2026. As the Company is a non-U.S. headquartered multinational, the “Side-by-Side” System itself does not apply to the Company’s tax profile. However, the broader guidance package also introduces a new permanent safe harbor (to replace the transitional CbCR safe harbor for fiscal years beginning in 2027) and a one-year extension of the transitional CbCR safe harbor that may potentially impact the Company’s Pillar Two compliance and reporting. The Company continues to monitor these developments but does not expect a material change to its Pillar Two liability.
v3.25.4
Balance Sheet Components
 9 Months Ended
Dec. 31, 2025
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components Balance Sheet Components
 
The following table presents the components of certain balance sheet asset amounts (in thousands): 
December 31, 2025March 31, 2025
Accounts receivable, net:  
Accounts receivable$1,136,982 $708,693 
Allowance for cooperative marketing arrangements
(71,059)(44,457)
Allowance for customer incentive programs
(144,573)(66,564)
Allowance for pricing programs
(194,731)(105,876)
Other allowances
(43,493)(37,250)
 $683,126 $454,546 
Inventories:  
Raw materials$47,369 $48,699 
Finished goods402,175 455,048 
 $449,544 $503,747 
Other current assets:  
Value-added tax ("VAT") receivables$55,552 $46,332 
Prepaid expenses and other assets111,436 84,879 
 $166,988 $131,211 
Property, plant and equipment, net:  
Property, plant and equipment$575,631 $543,747 
  Less: accumulated depreciation and amortization(460,268)(429,889)
$115,363 $113,858 
Other assets:  
Deferred tax assets$231,915 $202,180 
Right-of-use assets 74,810 75,239 
Investments for deferred compensation plan32,078 29,006 
Investments in privately held companies28,863 27,980 
Other assets14,714 9,672 
 $382,380 $344,077 
The following table presents the components of certain balance sheet liability amounts (in thousands): 
December 31, 2025March 31, 2025
Accrued and other current liabilities:  
Accrued customer marketing, pricing and incentive programs$232,284 $173,401 
Accrued personnel expenses152,729 180,763 
Income taxes payable70,768 26,841 
VAT payable51,128 29,648 
Deferred revenue (1)
37,598 25,798 
Warranty liabilities36,257 34,428 
Accrued sales return liability28,966 27,913 
Accrued loss for inventory purchase commitments22,493 19,614 
Operating lease liabilities17,467 15,780 
Other current liabilities168,234 152,317 
 $817,924 $686,503 
Other non-current liabilities:  
Operating lease liabilities$74,515 $76,622 
Employee benefit plan obligations60,265 57,338 
Deferred revenue (1)
49,896 38,216 
Obligation for deferred compensation plan32,078 29,006 
Warranty liabilities15,186 14,756 
Other non-current liabilities6,060 5,574 
 $238,000 $221,512 
(1) Includes deferred revenue for post-contract customer support and other services.
v3.25.4
Fair Value Measurements
 9 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
 
Fair Value Measurements
 
The Company considers fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Company utilizes the following three-level fair value hierarchy to establish the priorities of the inputs used to measure fair value:
 
•Level 1 — Quoted prices in active markets for identical assets or liabilities.
 
•Level 2 — Observable inputs other than quoted market prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
 
•Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis, excluding assets related to the Company’s defined benefit pension plans, classified by the level within the fair value hierarchy (in thousands): 
 December 31, 2025March 31, 2025
 Level 1Level 2Level 3Level 1Level 2Level 3
Assets:    
Cash equivalents$939,908 $— $— $852,467 $— $— 
Investments for deferred compensation plan included in other assets:    
Cash$99 $— $— $90 $— $— 
Common stock974 — — 540 — — 
Money market funds7,009 — — 7,359 — — 
Mutual funds23,996 — — 21,017 — — 
Total investments for deferred compensation plan$32,078 $— $— $29,006 $— $— 
Currency derivative assets$— $68 $— $— $90 $— 
Liabilities:
Currency derivative liabilities$— $5,924 $— $— $2,849 $— 

Investments for Deferred Compensation Plan

The marketable securities for the Company's deferred compensation plan were recorded at a fair value of $32.1 million and $29.0 million, as of December 31, 2025 and March 31, 2025, respectively, based on quoted market prices. Quoted market prices are observable inputs that are classified as Level 1 within the fair value hierarchy. Unrealized gains (losses) related to marketable securities for the three and nine months ended December 31, 2025 and 2024 were not material and are included in other income (expense), net and corresponding changes in the deferred compensation liability were included in operating expenses and cost of goods sold, in the Company's condensed consolidated statements of operations.

Equity Method Investments

The Company has certain non-marketable investments included in other assets that are accounted for as equity method investments, with a carrying value of $19.2 million and $18.4 million as of December 31, 2025 and March 31, 2025, respectively. Income (loss) related to equity method investments for the three and nine months ended December 31, 2025 and 2024 were not material and are included in other income (expense), net in the Company's condensed consolidated statements of operations. There was no impairment of equity method investments during the three and nine months ended December 31, 2025 and 2024.

Assets Measured at Fair Value on a Nonrecurring Basis

Financial Assets 

The Company has certain equity investments without readily determinable fair values due to the absence of quoted market prices, the inherent lack of liquidity, and the fact that inputs used to measure fair value are unobservable and require management's judgment. When certain events or circumstances indicate that impairment may exist, the Company revalues the investments using various assumptions, including the financial metrics and ratios of comparable public companies. The carrying value is also adjusted for observable price changes with the same or similar security from the same issuer. The amount of these equity investments without readily determinable fair value included in other assets was $8.8 million as of December 31, 2025 and March 31, 2025. There was no impairment of these equity investments during the three and nine months ended December 31, 2025. The impairment charges related to the equity investments were not material during the three and nine months ended December 31, 2024.
Non-Financial Assets
Goodwill, intangible assets, and property, plant and equipment, are not required to be measured at fair value on a recurring basis. However, if the Company is required to evaluate these non-financial assets for impairment, whether due to certain triggering events or because of the required annual impairment test, and a resulting impairment is recorded to reduce the carrying value to the fair value, the non-financial assets are measured at fair value during such period. There was no impairment of non-financial assets during the three and nine months ended December 31, 2025 and 2024.
v3.25.4
Derivative Financial Instruments
 9 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
 
Under certain agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same type with a single net amount payable by one party to the other. However, the Company presents its derivative assets and derivative liabilities on a gross basis. Based on maturity, derivative assets are included in other current assets or other assets and derivative liabilities are included in accrued and other current liabilities or other non-current liabilities on the condensed consolidated balance sheets. See Note 6 for the fair values of the Company’s derivative instruments as of December 31, 2025 and March 31, 2025.

Cash Flow Hedges

The Company enters into cash flow hedge contracts, including foreign currency forward contracts and foreign currency option contracts, to protect against exchange rate exposure of forecasted inventory purchases. Previously, the hedge contracts covered inventory purchases within four months. Beginning in fiscal year 2026, they cover inventory purchases up to sixteen months, with reduced coverage beyond four months. Gains and losses in the fair value of the effective portion of the hedges are deferred as a component of accumulated other comprehensive income (loss) until the hedged inventory purchases are sold, at which time the gains or losses are reclassified to cost of goods sold. Cash flows from such hedges are classified as operating activities in the condensed consolidated statements of cash flows. Hedging relationships are discontinued when the hedging contract is no longer eligible for hedge accounting, or is sold, terminated or exercised, or when the Company removes hedge designation for the contract. Gains and losses in the fair value of the effective portion of the discontinued hedges continue to be reported in accumulated other comprehensive income (loss) until the hedged inventory purchases are sold, unless it is probable that the forecasted inventory purchases will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter.

The notional amounts of foreign currency exchange contracts outstanding related to forecasted inventory purchases were $444.5 million and $74.6 million as of December 31, 2025 and March 31, 2025, respectively. The Company had $8.3 million of net loss related to its cash flow hedges included in accumulated other comprehensive loss as of December 31, 2025, which will be reclassified into earnings within the next twelve months.
The following table presents the amounts of gain (loss) on the Company’s derivative instruments designated as hedging instruments for the three and nine months ended December 31, 2025 and 2024 and their locations on its condensed consolidated statements of operations and condensed consolidated statements of comprehensive income (in thousands):
Three Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss 		Amount of Loss
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
 2025202420252024
Cash flow hedges$(5,047)$3,577 $3,328 $790 
Nine Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss		Amount of Loss (Gain)
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
2025202420252024
Cash flow hedges$(16,807)$2,228 $11,291 $(849)
 
Other Derivatives
 
The Company also enters into foreign currency exchange forward and swap contracts to reduce the short-term effects of currency exchange rate fluctuations on certain receivables or payables denominated in currencies other than the functional currencies of its subsidiaries. These contracts generally mature within approximately one month. The primary risk managed by using forward and swap contracts is the currency exchange rate risk. The gains or losses on these contracts are not material and are included in other income (expense), net, in the condensed consolidated statements of operations based on the changes in fair value. The notional amounts of these contracts outstanding as of December 31, 2025 and March 31, 2025 were $95.0 million and $131.8 million, respectively.
 
The fair value of all foreign currency exchange forward and swap contracts is determined based on observable market transactions of spot currency rates and forward rates. Cash flows from these contracts are classified as operating activities in the condensed consolidated statements of cash flows.
v3.25.4
Goodwill and Other Intangible Assets
 9 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
The Company conducts its impairment analysis of goodwill annually at December 31 or more frequently if changes in facts and circumstances indicate that it is more likely than not that the fair value of the Company’s reporting unit may be less than its carrying amount. The Company conducted its annual impairment analysis of goodwill as of December 31, 2025 by performing a qualitative assessment and concluded that it was more likely than not that the fair value of its reporting unit exceeds its carrying amount.

The following table summarizes the activities in the Company’s goodwill balance (in thousands):

As of March 31, 2025$463,230 
Effects of foreign currency translation3,349 
As of December 31, 2025$466,579 
The Company's acquired intangible assets were as follows (in thousands):
 December 31, 2025March 31, 2025
 Gross Carrying AmountAccumulated
Amortization		Net Carrying AmountGross Carrying AmountAccumulated
Amortization		Net Carrying Amount
Trademarks and trade names$32,390 $(30,282)$2,108 $32,390 $(28,675)$3,715 
Developed technology107,421 (102,253)5,168 107,421 (96,464)10,957 
Customer contracts/relationships69,087 (62,393)6,694 69,087 (58,646)10,441 
Effects of foreign currency translation988 (1,069)(81)(620)137 (483)
Total$209,886 $(195,997)$13,889 $208,278 $(183,648)$24,630 
v3.25.4
Financing Arrangements
 9 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Financing Arrangements Financing Arrangements
 
On January 27, 2025, the Company entered into an unsecured revolving credit facility with a syndicate of banks (the "Credit Agreement"). The Credit Agreement provides a revolving line of credit of up to $750.0 million to the Company including the issuance of letters of credit of up to $100.0 million. The Credit Agreement terminates on January 27, 2030 unless extended in accordance with its terms. The Credit Agreement contains (1) an increase option allowing the Company to secure up to $250.0 million of additional commitments and (2) an extension option to extend the term by one-year which may be exercised no more than two times, subject to certain requirements. Loans under the Credit Agreement are available in U.S. Dollars, Euro, Sterling, Yen, Swiss Francs, Canadian Dollars, Australian Dollars and any other currency agreed to by each lender. Proceeds of loans made under the Credit Agreement may be used for general corporate purposes.

The Credit Agreement contains a maximum net debt to adjusted EBITDA ratio, compliance with which is a condition to the Company's ability to borrow. Borrowings under the Credit Agreement will bear interest at a rate determined by reference to benchmark rates plus an applicable spread (ranging from 0% to 1.5%) based on the Company's net leverage ratio or credit rating at the time of the borrowing. Undrawn balances available under the Credit Agreement are subject to commitment fees at the applicable rate determined by reference to the Company's net leverage ratio or credit rating. There has been no borrowing outstanding under the Credit Agreement as of December 31, 2025.
In addition, the Company had several uncommitted, unsecured bank lines of credit and letters of credit aggregating to $164.0 million and $172.2 million as of December 31, 2025 and March 31, 2025, respectively. There are no financial covenants under the lines of credit with which the Company must comply. There was no borrowing outstanding under the lines of credit as of December 31, 2025 or March 31, 2025. As of December 31, 2025 and March 31, 2025, the Company had outstanding bank guarantees of $8.5 million and $12.1 million, respectively.
v3.25.4
Commitments and Contingencies
 9 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
 
Product Warranties
 
Changes in the Company’s warranty liabilities for the three and nine months ended December 31, 2025 and 2024 were as follows (in thousands): 
Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Beginning of the period$50,191 $46,833 $49,184 $44,654 
Provision9,430 12,060 28,424 34,022 
Settlements(8,438)(9,111)(27,079)(29,124)
Effects of foreign currency translation260 (721)914 (491)
End of the period$51,443 $49,061 $51,443 $49,061 
Indemnifications
 
The Company indemnifies certain of its suppliers and customers for losses arising from matters such as intellectual property disputes and product safety defects, subject to certain restrictions. The scope of these indemnities varies, but in some instances includes indemnification for damages and expenses, including reasonable attorneys’ fees. As of December 31, 2025, no material amounts have been accrued for these indemnification provisions. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under its indemnification arrangements.
 
The Company also indemnifies its current and former directors and certain of its current and former officers. Certain costs incurred for providing such indemnification may be recoverable under various insurance policies. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements because these exposures are not limited, the obligations are conditional in nature, and the facts and circumstances involved in any situation that might arise are variable.

Legal Proceedings

From time to time the Company is involved in claims and legal proceedings that arise in the ordinary course of its business. The Company is currently subject to several such claims and legal proceedings. The Company intends to vigorously defend against them. Management periodically assesses the Company’s liabilities and contingencies in connection with these matters based upon the latest information available. The Company follows ASC ("Accounting Standards Codification") 450, Contingencies, in determining the accounting and disclosure for these contingencies. Based on currently available information, the Company does not believe that resolution of pending matters will have a material adverse effect on its financial condition, cash flows, and results of operations. However, litigation is subject to inherent uncertainties, and there can be no assurances that the Company's defenses will be successful or that any such lawsuit or claim would not have a material adverse impact on the Company's business, financial condition, cash flows and results of operations in a particular period. Any claims or proceedings against the Company can have an adverse impact because of defense costs, diversion of management and operational resources, negative publicity, and other factors. Any failure to obtain a necessary license or other rights, or litigation arising out of intellectual property claims, could adversely affect the Company's business.
v3.25.4
Shareholders' Equity
 9 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ Equity
Share Capital

As of December 31, 2025, the Company's nominal share capital is CHF 40.2 million, consisting of 160,784,460 issued shares with a par value of CHF 0.25 each, of which 14,026,614 were held in treasury shares.

The capital band under Swiss law allows a company's board of directors to adjust the company's share capital within a predefined range based on a general authority granted by the company's shareholders. At the 2023 Annual General Meeting ("AGM"), the Company's shareholders approved an amendment to the Company’s Articles of Incorporation to introduce a capital band provision authorizing the Board of Directors to adjust the Company's share capital, without additional shareholder approval, within a range of 155,795,958 registered shares to 190,417,282 registered shares for a five-year period ending on September 13, 2028. At the 2025 AGM, the Company's shareholders approved a renewal of the capital band, setting a new range of 144,706,014 registered shares to 176,862,906 registered shares for a five-year period ending on September 9, 2030. The amendment became effective on October 1, 2025.

In addition, the Company has reserved conditional capital (1) up to 25,000,000 shares for potential issuance for the exercise of rights granted under the Company's employee equity incentive plans, and (2) up to 25,000,000 shares for issuance to cover any conversion rights under any potential future convertible bond issuance.

Share Repurchases

In June 2023, the Company's Board of Directors approved a three-year share repurchase program, which allows the Company to use up to $1.0 billion to repurchase its shares. The 2023 share repurchase program enables the Company to repurchase shares for cancellation, as well as to support equity incentive plans or potential acquisitions. The Swiss Takeover Board approved the 2023 share repurchase program in July 2023 and the program became effective on July 28, 2023. In March 2025, the Company's Board of Directors approved an
increase of $600.0 million to the 2023 share repurchase program, to an aggregate amount of $1.6 billion. The Swiss Takeover Board approved this increase in April 2025 and it became effective on April 2, 2025. As of December 31, 2025, $409.5 million was available for repurchase under the 2023 share repurchase program.

The following table summarizes the Company's share repurchase activities for the nine months ended December 31, 2025 and 2024 were as follows (in thousands):

Nine Months Ended
December 31,
20252024
2023 Share Repurchase Program:
  Number of shares repurchased (1)
2,6785,328
  Aggregate cost of shares repurchased (1) (2)
$239,056 $461,402 
(1) All shares were repurchased for cancellation.
(2) Includes an aggregate cost of $2.4 million and $17.6 million, respectively, that was not yet paid as of December 31, 2025 and 2024.

Swiss law limits a company’s ability to hold or repurchase its own shares. The aggregate par value of all shares held in treasury by the Company and its subsidiaries may not exceed 10% of the share capital of the Company, which for the Company corresponds to approximately 16.1 million registered shares as of December 31, 2025. This limitation does not apply to shares repurchased for cancellation, due to the Board of Directors’ authority under the Company’s capital band set forth in the Company’s Articles of Incorporation. As of December 31, 2025, the Company had a total of 14.0 million shares held in treasury stock, which includes 1.1 million shares that have been repurchased for cancellation and 12.9 million shares that have been purchased to support equity incentive plans or potential acquisitions.

To the extent that the shares are repurchased to support equity incentive plans or potential acquisitions, the shares are repurchased on the ordinary trading line of the SIX Swiss Exchange (“SIX”) and/or The Nasdaq Global Select Market (“Nasdaq”). Shares repurchased for cancellation purposes are repurchased on a second trading line on the SIX. Shares may be repurchased from time to time on the open market or in privately negotiated transactions, including under plans complying with the provisions of Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. Purchases may be started or stopped at any time without prior notice depending on market conditions and other factors and the program does not require the purchase of any minimum number of shares.

Share Cancellation

In June 2025, the Company's Board of Directors approved the cancellation of 8.2 million treasury shares, which were repurchased under the 2023 share repurchase program in fiscal year 2025 and the first quarter of fiscal year 2026, for an aggregate cost of $712.2 million. The cancellation became effective in the second quarter of fiscal year 2026, and as a result, both the number of registered shares issued and the number of treasury shares decreased by 8.2 million shares. Upon cancellation of these shares, the Company deducted the par value from registered shares and reflected the excess of share repurchase cost over par value as a reduction to retained earnings.

Dividends

During the nine months ended December 31, 2025, the Company declared cash dividends of CHF 1.26 (USD equivalent of $1.58 based on the exchange rate on the date of declaration) per share and paid a total of $233.1 million on the Company's outstanding shares. During the nine months ended December 31, 2024, the Company declared cash dividends of CHF 1.16 (USD equivalent of $1.37 based on the exchange rate on the date of declaration) per share and paid a total of $207.9 million on the Company's outstanding shares.

Any future dividends will be subject to approval of the Company's shareholders.
Accumulated Other Comprehensive Loss
 
The components of accumulated other comprehensive loss were as follows (in thousands):
Currency Translation Adjustment
Defined Benefit Plans
Deferred Hedging Losses
Total
March 31, 2025$(118,652)$(25,276)$(3,024)$(146,952)
Other comprehensive income (loss)26,874 (531)(5,516)20,827 
December 31, 2025$(91,778)$(25,807)$(8,540)$(126,125)
v3.25.4
Segment Information
 9 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
 
The Company manages its business activities on a consolidated basis and operates as a single operating segment: Peripherals. The operating segment encompasses the design, manufacturing and sales of peripherals for gaming, PCs, tablets, video conferencing, and other digital platforms. The Company's Chief Operating Decision Maker (the “CODM”) is the Chief Executive Officer. The CODM periodically reviews information such as sales and net income to make business decisions and evaluate performance. The CODM uses net income to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the Peripherals segment or into other parts of the entity, such as for acquisitions, share repurchase or to pay dividends. The CODM also monitors budget versus actual net income results.

The following table presents segment revenue, significant segment expenses, and net income (in thousands):
Three Months Ended
December 31,		Nine Months Ended
December 31,
2025202420252024
Net sales
$1,421,479 $1,340,294 $3,755,238 $3,544,545 
Less: Significant segment expenses
Cost of goods sold (1)
802,631 761,230 2,132,902 2,001,738 
Marketing and selling (1)
200,964 205,235 569,682 581,683 
Research and development (1)
73,057 72,930 211,737 213,636 
General and administrative (1)
32,428 34,953 96,714 106,336 
Less: other segment items
  Share-based compensation expense23,435 26,193 86,575 76,067 
  Amortization of intangible assets and
  acquisition-related costs
2,488 5,087 11,283 15,409 
  Interest income
(10,985)(12,176)(34,042)(42,603)
  Other (2)
(1,669)1,634 3,717 3,614 
  Provision for income taxes
48,091 45,061 108,946 101,202 
Net income
$251,039 $200,147 $567,724 $487,463 
(1) The difference between the amounts included in the table above and the amounts included in the condensed consolidated statements of operations is related to share-based compensation expense (see Note 3).
(2) Includes restructuring charges, net, and other income (expense), net.
Sales by product category for the three and nine months ended December 31, 2025 and 2024 were as follows (in thousands):

Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Gaming (1)
$482,714 $466,715 $1,121,894 $1,076,660 
Keyboards & Combos254,612 236,748 712,974 662,017 
Pointing Devices241,160 217,045 658,034 602,927 
Video Collaboration193,252 176,053 527,645 482,755 
Webcams82,268 84,419 249,944 237,572 
Tablet Accessories93,567 77,433 269,855 241,586 
Headsets45,939 45,886 134,959 137,038 
Other (2)
27,967 35,995 79,933 103,990 
Total Sales$1,421,479 $1,340,294 $3,755,238 $3,544,545 
(1) Gaming includes streaming services revenue generated by Streamlabs.
(2) Other primarily consists of mobile speakers and PC speakers.

Sales by geographic region (based on the customers’ locations) for the three and nine months ended December 31, 2025 and 2024 were as follows (in thousands):
Three Months Ended
December 31,		Nine Months Ended
December 31,
2025202420252024
Americas$556,358 $553,563 $1,480,784 $1,518,933 
EMEA485,731 454,665 1,214,948 1,116,368 
Asia Pacific379,390 332,066 1,059,506 909,244 
Total Sales$1,421,479 $1,340,294 $3,755,238 $3,544,545 
 
Revenue from sales to customers in the United States, Germany and China each represented 10% or more of the total consolidated sales for each of the three and nine months ended December 31, 2025 and 2024. No other countries represented 10% or more of the Company’s total consolidated sales for the periods presented herein.

Switzerland, the Company’s country of domicile, represented 4% of the Company's total consolidated sales for each of the three and nine months ended December 31, 2025, and 3% of the Company's total consolidated sales for each of the three and nine months ended December 31, 2024.

Three customers of the Company each represented 10% or more of the total consolidated gross sales for each of the three and nine months ended December 31, 2025 and 2024.

Property, plant and equipment, net (excluding software) and right-of-use assets by geographic region were as follows (in thousands):
December 31, 2025March 31, 2025
Americas$60,604 $61,521 
EMEA50,494 47,874 
Asia Pacific62,222 60,710 
Total$173,320 $170,105 

Property, plant and equipment, net (excluding software) and right-of-use assets in the United States and China, were $59.1 million and $45.6 million, respectively, as of December 31, 2025. Property, plant and equipment, net (excluding software) and right-of-use assets in the United States and China were $60.0 million and $43.4 million, respectively, as of March 31, 2025.
Property, plant and equipment, net (excluding software) and right-of-use assets in Switzerland, the Company’s country of domicile, were $26.1 million and $24.1 million as of December 31, 2025 and March 31, 2025, respectively. No other countries represented more than 10% of the Company’s total property, plant and equipment, net (excluding software) and right-of-use assets as of December 31, 2025 or March 31, 2025.
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
The Company and Summary of Significant Accounting Policies and Estimates (Policies)
 9 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation and Changes in Significant Accounting Policies
Basis of Presentation

The condensed consolidated financial statements include the accounts of Logitech and its subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and therefore do not include all the information required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 23, 2025.

In the opinion of management, these condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary and in all material aspects, for a fair statement of the results of operations, comprehensive income, financial position, cash flows and changes in shareholders' equity for the periods presented. Operating results for the three and nine months ended December 31, 2025 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2026, or any future periods.

Changes in Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies during the three and nine months ended December 31, 2025 compared with the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Significant estimates and assumptions made by management involve the fair value of goodwill and intangible assets acquired from business acquisitions, pension obligations, accruals for customer incentives, cooperative marketing, and pricing programs and related breakage when appropriate, inventory valuation, share-based compensation expense, uncertain tax positions, and valuation allowances for deferred tax assets. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results could differ materially from those estimates.
Risks and Uncertainties
Risks and Uncertainties

Impacts of Macroeconomic, Geopolitical, and Other Factors on the Company's Business

In 2025, the United States introduced trade policy actions that have increased import tariffs across a wide range of countries at various rates, with certain exemptions. These tariff policies in the U.S. and responsive policies enacted in other countries are evolving. The incremental tariffs have had and may continue to have an adverse impact on the Company's results of operations. The Company may also be affected by the increases in demand for memory chips and other components caused by the build out of new AI technologies and data centers, leading to a rise in prices for such components and suppliers transitioning away from supplying certain components utilized in the manufacturing of some of the Company’s Video Collaboration products. In addition, the Company's business has continued to be impacted by ongoing macroeconomic and geopolitical conditions. These conditions include inflation, interest rate and foreign currency fluctuations, uncertainty in consumer and enterprise demand, low economic growth in certain regions, changes in fiscal policies and geopolitical conflicts.

The global and regional macroeconomic and political conditions, as well as changes in trade policies and memory supply, have caused and may continue to cause volatility in demand for the Company's products, component availability, transit times, and cost of the Company's products including cost of tariffs, materials, and logistics, and as a result, have impacted and may continue to impact the pricing of the Company's products, product availability and the Company's results of operations.
New Accounting Pronouncements Not Yet Adopted
New Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires additional disclosures related to rate reconciliation, income taxes paid, and other disclosures. Under ASU 2023-09, for each annual period presented, public entities are required to (1) disclose specific categories in the tabular rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. In addition, ASU 2023-09 requires all reporting entities to disclose on an annual basis the amount of income taxes paid disaggregated by federal, state, and foreign taxes as well as the amount of income taxes paid by individual jurisdiction. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 and can be applied on a prospective basis with an option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2023-09 on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. ASU 2024-03 requires all public entities to disclose in the notes to the financial statements the amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption of the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. ASU 2024-03 can be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2024-03 on its consolidated financial statements and related disclosures.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. ASU 2025-05 provides a practical expedient that permits entities to assume that current conditions as of the balance sheet date will remain unchanged over the remaining life of current accounts receivable and current contract assets when estimating the expected credit losses. ASU 2025-05 is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted. ASU 2025-05 should be applied on a prospective basis. The Company is currently evaluating the impact of ASU 2025-05 on its consolidated financial statements and related disclosures.
In September 2025, the FASB issued ASU No. 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 updates the cost capitalization threshold for internal-use software development costs by removing all references to software project development stages and providing new guidance on how to evaluate whether the probable-to-complete recognition threshold has been met. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted. ASU 2025-06 can be applied on a prospective basis, with retrospective or modified retrospective application permitted. The Company is currently evaluating the impact of ASU 2025-06 on its consolidated financial statements and related disclosures.
Segment Information Segment Information
 
The Company manages its business activities on a consolidated basis and operates as a single operating segment: Peripherals. The operating segment encompasses the design, manufacturing and sales of peripherals for gaming, PCs, tablets, video conferencing, and other digital platforms. The Company's Chief Operating Decision Maker (the “CODM”) is the Chief Executive Officer. The CODM periodically reviews information such as sales and net income to make business decisions and evaluate performance. The CODM uses net income to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the Peripherals segment or into other parts of the entity, such as for acquisitions, share repurchase or to pay dividends. The CODM also monitors budget versus actual net income results.
v3.25.4
Net Income Per Share (Tables)
 9 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Computations of Basic and Diluted Net Income Per Share
The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2025 and 2024 (in thousands, except per share amounts):
Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Net income$251,039 $200,147 $567,724 $487,463 
Shares used in net income per share computation:    
Weighted average shares outstanding - basic146,827 150,647 147,265 152,127 
Effect of potentially dilutive equivalent shares1,623 1,248 1,370 1,379 
Weighted average shares outstanding - diluted148,450 151,895 148,635 153,506 
Net income per share:    
Basic$1.71 $1.33 $3.86 $3.20 
Diluted$1.69 $1.32 $3.82 $3.18 
v3.25.4
Employee Benefit Plans (Tables)
 9 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expenses and Related Tax Benefits Recognized
The following table summarizes share-based compensation expense and total income tax benefit recognized for the three and nine months ended December 31, 2025 and 2024 (in thousands):
Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Cost of goods sold$2,636 $2,173 $8,375 $8,673 
Marketing and selling5,911 11,813 31,982 34,133 
Research and development5,395 5,043 17,412 15,849 
General and administrative9,493 7,164 28,806 17,412 
Total share-based compensation expense23,435 26,193 86,575 76,067 
Income tax benefit(4,699)(4,523)(15,620)(16,901)
Total share-based compensation expense, net of income tax benefit$18,736 $21,670 $70,955 $59,166 
v3.25.4
Balance Sheet Components (Tables)
 9 Months Ended
Dec. 31, 2025
Balance Sheet Related Disclosures [Abstract]  
Schedule of Components of Certain Balance Sheet Asset Amounts
The following table presents the components of certain balance sheet asset amounts (in thousands): 
December 31, 2025March 31, 2025
Accounts receivable, net:  
Accounts receivable$1,136,982 $708,693 
Allowance for cooperative marketing arrangements
(71,059)(44,457)
Allowance for customer incentive programs
(144,573)(66,564)
Allowance for pricing programs
(194,731)(105,876)
Other allowances
(43,493)(37,250)
 $683,126 $454,546 
Inventories:  
Raw materials$47,369 $48,699 
Finished goods402,175 455,048 
 $449,544 $503,747 
Other current assets:  
Value-added tax ("VAT") receivables$55,552 $46,332 
Prepaid expenses and other assets111,436 84,879 
 $166,988 $131,211 
Property, plant and equipment, net:  
Property, plant and equipment$575,631 $543,747 
  Less: accumulated depreciation and amortization(460,268)(429,889)
$115,363 $113,858 
Other assets:  
Deferred tax assets$231,915 $202,180 
Right-of-use assets 74,810 75,239 
Investments for deferred compensation plan32,078 29,006 
Investments in privately held companies28,863 27,980 
Other assets14,714 9,672 
 $382,380 $344,077 
Schedule of Components of Certain Balance Sheet Liability Amounts
The following table presents the components of certain balance sheet liability amounts (in thousands): 
December 31, 2025March 31, 2025
Accrued and other current liabilities:  
Accrued customer marketing, pricing and incentive programs$232,284 $173,401 
Accrued personnel expenses152,729 180,763 
Income taxes payable70,768 26,841 
VAT payable51,128 29,648 
Deferred revenue (1)
37,598 25,798 
Warranty liabilities36,257 34,428 
Accrued sales return liability28,966 27,913 
Accrued loss for inventory purchase commitments22,493 19,614 
Operating lease liabilities17,467 15,780 
Other current liabilities168,234 152,317 
 $817,924 $686,503 
Other non-current liabilities:  
Operating lease liabilities$74,515 $76,622 
Employee benefit plan obligations60,265 57,338 
Deferred revenue (1)
49,896 38,216 
Obligation for deferred compensation plan32,078 29,006 
Warranty liabilities15,186 14,756 
Other non-current liabilities6,060 5,574 
 $238,000 $221,512 
(1) Includes deferred revenue for post-contract customer support and other services.
v3.25.4
Fair Value Measurements (Tables)
 9 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities, Classified by Level
The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis, excluding assets related to the Company’s defined benefit pension plans, classified by the level within the fair value hierarchy (in thousands): 
 December 31, 2025March 31, 2025
 Level 1Level 2Level 3Level 1Level 2Level 3
Assets:    
Cash equivalents$939,908 $— $— $852,467 $— $— 
Investments for deferred compensation plan included in other assets:    
Cash$99 $— $— $90 $— $— 
Common stock974 — — 540 — — 
Money market funds7,009 — — 7,359 — — 
Mutual funds23,996 — — 21,017 — — 
Total investments for deferred compensation plan$32,078 $— $— $29,006 $— $— 
Currency derivative assets$— $68 $— $— $90 $— 
Liabilities:
Currency derivative liabilities$— $5,924 $— $— $2,849 $— 
v3.25.4
Derivative Financial Instruments (Tables)
 9 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Gains on Derivative Instruments
The following table presents the amounts of gain (loss) on the Company’s derivative instruments designated as hedging instruments for the three and nine months ended December 31, 2025 and 2024 and their locations on its condensed consolidated statements of operations and condensed consolidated statements of comprehensive income (in thousands):
Three Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss 		Amount of Loss
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
 2025202420252024
Cash flow hedges$(5,047)$3,577 $3,328 $790 
Nine Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss		Amount of Loss (Gain)
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
2025202420252024
Cash flow hedges$(16,807)$2,228 $11,291 $(849)
v3.25.4
Goodwill and Other Intangible Assets (Tables)
 9 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Activity in Goodwill Balance
The following table summarizes the activities in the Company’s goodwill balance (in thousands):

As of March 31, 2025$463,230 
Effects of foreign currency translation3,349 
As of December 31, 2025$466,579 
Schedule of Intangible Assets Subject to Amortization
The Company's acquired intangible assets were as follows (in thousands):
 December 31, 2025March 31, 2025
 Gross Carrying AmountAccumulated
Amortization		Net Carrying AmountGross Carrying AmountAccumulated
Amortization		Net Carrying Amount
Trademarks and trade names$32,390 $(30,282)$2,108 $32,390 $(28,675)$3,715 
Developed technology107,421 (102,253)5,168 107,421 (96,464)10,957 
Customer contracts/relationships69,087 (62,393)6,694 69,087 (58,646)10,441 
Effects of foreign currency translation988 (1,069)(81)(620)137 (483)
Total$209,886 $(195,997)$13,889 $208,278 $(183,648)$24,630 
v3.25.4
Commitments and Contingencies (Tables)
 9 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Changes in Warranty Liabilities
Changes in the Company’s warranty liabilities for the three and nine months ended December 31, 2025 and 2024 were as follows (in thousands): 
Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Beginning of the period$50,191 $46,833 $49,184 $44,654 
Provision9,430 12,060 28,424 34,022 
Settlements(8,438)(9,111)(27,079)(29,124)
Effects of foreign currency translation260 (721)914 (491)
End of the period$51,443 $49,061 $51,443 $49,061 
v3.25.4
Shareholders' Equity (Tables)
 9 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Accelerated Share Repurchases
The following table summarizes the Company's share repurchase activities for the nine months ended December 31, 2025 and 2024 were as follows (in thousands):

Nine Months Ended
December 31,
20252024
2023 Share Repurchase Program:
  Number of shares repurchased (1)
2,6785,328
  Aggregate cost of shares repurchased (1) (2)
$239,056 $461,402 
(1) All shares were repurchased for cancellation.
(2) Includes an aggregate cost of $2.4 million and $17.6 million, respectively, that was not yet paid as of December 31, 2025 and 2024.
Schedule of Components of Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss were as follows (in thousands):
Currency Translation Adjustment
Defined Benefit Plans
Deferred Hedging Losses
Total
March 31, 2025$(118,652)$(25,276)$(3,024)$(146,952)
Other comprehensive income (loss)26,874 (531)(5,516)20,827 
December 31, 2025$(91,778)$(25,807)$(8,540)$(126,125)
v3.25.4
Segment Information (Tables)
 9 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents segment revenue, significant segment expenses, and net income (in thousands):
Three Months Ended
December 31,		Nine Months Ended
December 31,
2025202420252024
Net sales
$1,421,479 $1,340,294 $3,755,238 $3,544,545 
Less: Significant segment expenses
Cost of goods sold (1)
802,631 761,230 2,132,902 2,001,738 
Marketing and selling (1)
200,964 205,235 569,682 581,683 
Research and development (1)
73,057 72,930 211,737 213,636 
General and administrative (1)
32,428 34,953 96,714 106,336 
Less: other segment items
  Share-based compensation expense23,435 26,193 86,575 76,067 
  Amortization of intangible assets and
  acquisition-related costs
2,488 5,087 11,283 15,409 
  Interest income
(10,985)(12,176)(34,042)(42,603)
  Other (2)
(1,669)1,634 3,717 3,614 
  Provision for income taxes
48,091 45,061 108,946 101,202 
Net income
$251,039 $200,147 $567,724 $487,463 
(1) The difference between the amounts included in the table above and the amounts included in the condensed consolidated statements of operations is related to share-based compensation expense (see Note 3).
(2) Includes restructuring charges, net, and other income (expense), net.
Schedule of Net Sales by Product Categories, Excluding Intercompany Transactions
Sales by product category for the three and nine months ended December 31, 2025 and 2024 were as follows (in thousands):

Three Months Ended
December 31,		Nine Months Ended
December 31,
 2025202420252024
Gaming (1)
$482,714 $466,715 $1,121,894 $1,076,660 
Keyboards & Combos254,612 236,748 712,974 662,017 
Pointing Devices241,160 217,045 658,034 602,927 
Video Collaboration193,252 176,053 527,645 482,755 
Webcams82,268 84,419 249,944 237,572 
Tablet Accessories93,567 77,433 269,855 241,586 
Headsets45,939 45,886 134,959 137,038 
Other (2)
27,967 35,995 79,933 103,990 
Total Sales$1,421,479 $1,340,294 $3,755,238 $3,544,545 
(1) Gaming includes streaming services revenue generated by Streamlabs.
(2) Other primarily consists of mobile speakers and PC speakers.
Schedule of Net Sales by Geographic Region
Sales by geographic region (based on the customers’ locations) for the three and nine months ended December 31, 2025 and 2024 were as follows (in thousands):
Three Months Ended
December 31,		Nine Months Ended
December 31,
2025202420252024
Americas$556,358 $553,563 $1,480,784 $1,518,933 
EMEA485,731 454,665 1,214,948 1,116,368 
Asia Pacific379,390 332,066 1,059,506 909,244 
Total Sales$1,421,479 $1,340,294 $3,755,238 $3,544,545 
Schedule of Long-Lived Assets by Geographic Region
Property, plant and equipment, net (excluding software) and right-of-use assets by geographic region were as follows (in thousands):
December 31, 2025March 31, 2025
Americas$60,604 $61,521 
EMEA50,494 47,874 
Asia Pacific62,222 60,710 
Total$173,320 $170,105 
v3.25.4
Net Income Per Share - Computations of Basic and Diluted Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Net income        
Net income $ 251,039 $ 200,147 $ 567,724 $ 487,463
Net income $ 251,039 $ 200,147 $ 567,724 $ 487,463
Shares used in net income per share computation:        
Weighted average shares outstanding - basic (in shares) 146,827 150,647 147,265 152,127
Effect of potentially dilutive equivalent shares (in shares) 1,623 1,248 1,370 1,379
Weighted average shares outstanding - diluted (in shares) 148,450 151,895 148,635 153,506
Net income per share:        
Basic (in dollars per share) $ 1.71 $ 1.33 $ 3.86 $ 3.20
Diluted (in dollars per share) $ 1.69 $ 1.32 $ 3.82 $ 3.18
v3.25.4
Net Income Per Share - Narrative (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Earnings Per Share [Abstract]        
Anti-dilutive equivalents shares excluded (in shares) 0.0 0.8 0.6 0.9
v3.25.4
Employee Benefit Plans - Schedule of Share-based Compensation Expenses and Related Tax Benefits Recognized (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Share-based compensation expense and related tax benefit        
Total share-based compensation expense $ 23,435 $ 26,193 $ 86,575 $ 76,067
Income tax benefit (4,699) (4,523) (15,620) (16,901)
Total share-based compensation expense, net of income tax benefit 18,736 21,670 70,955 59,166
Cost of goods sold        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense 2,636 2,173 8,375 8,673
Marketing and selling        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense 5,911 11,813 31,982 34,133
Research and development        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense 5,395 5,043 17,412 15,849
General and administrative        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense $ 9,493 $ 7,164 $ 28,806 $ 17,412
v3.25.4
Employee Benefit Plans - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]        
Share-based compensation expenses capitalized as inventory $ 1.9 $ 1.6 $ 6.7 $ 5.9
Net periodic benefit cost $ 1.7 $ 1.8 $ 5.2 $ 5.3
v3.25.4
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]        
Provision for income taxes $ 48,091 $ 45,061 $ 108,946 $ 101,202
Effective income tax rates (as a percent) 16.10% 18.40% 16.10% 17.20%
v3.25.4
Balance Sheet Components - Schedule of Components of Certain Balance Sheet Asset Amounts (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Accounts receivable, net:    
Accounts receivable $ 1,136,982 $ 708,693
Accounts receivable, net 683,126 454,546
Inventories:    
Raw materials 47,369 48,699
Finished goods 402,175 455,048
Inventory, net 449,544 503,747
Other current assets:    
Value-added tax ("VAT") receivables 55,552 46,332
Prepaid expenses and other assets 111,436 84,879
Other current assets, total 166,988 131,211
Property, plant and equipment, net:    
Property, plant and equipment 575,631 543,747
Less: accumulated depreciation and amortization (460,268) (429,889)
Property, plant and equipment, net 115,363 113,858
Other assets:    
Deferred tax assets 231,915 202,180
Right-of-use assets 74,810 75,239
Investments for deferred compensation plan 32,078 29,006
Other assets 14,714 9,672
Other assets, total 382,380 344,077
Investments in privately held companies    
Other assets:    
Investments in privately held companies 28,863 27,980
Allowance for cooperative marketing arrangements    
Accounts receivable, net:    
Valuation allowance for accounts receivable (71,059) (44,457)
Allowance for customer incentive programs    
Accounts receivable, net:    
Valuation allowance for accounts receivable (144,573) (66,564)
Allowance for pricing programs    
Accounts receivable, net:    
Valuation allowance for accounts receivable (194,731) (105,876)
Other allowances    
Accounts receivable, net:    
Valuation allowance for accounts receivable $ (43,493) $ (37,250)
v3.25.4
Balance Sheet Components - Schedule of Components of Certain Balance Sheet Liability Amounts (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Accrued and other current liabilities:    
Accrued customer marketing, pricing and incentive programs $ 232,284 $ 173,401
Accrued personnel expenses 152,729 180,763
Income taxes payable 70,768 26,841
VAT payable 51,128 29,648
Deferred revenue 37,598 25,798
Warranty liabilities 36,257 34,428
Accrued sales return liability 28,966 27,913
Accrued loss for inventory purchase commitments 22,493 19,614
Operating lease liabilities 17,467 15,780
Other current liabilities 168,234 152,317
Accrued and other current liabilities 817,924 686,503
Other non-current liabilities:    
Operating lease liabilities 74,515 76,622
Employee benefit plan obligations 60,265 57,338
Deferred revenue 49,896 38,216
Obligation for deferred compensation plan 32,078 29,006
Warranty liabilities 15,186 14,756
Other non-current liabilities 6,060 5,574
Non-current liabilities $ 238,000 $ 221,512
v3.25.4
Fair Value Measurements - Schedule of Financial Assets and Liabilities, Classified by Level (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Deferred compensation    
Assets:    
Investments for deferred compensation plan $ 28,863 $ 27,980
Level 1    
Assets:    
Cash equivalents 939,908 852,467
Investments for deferred compensation plan 32,078 29,006
Currency derivative assets 0 0
Liabilities:    
Currency derivative liabilities 0 0
Level 1 | Deferred compensation | Cash    
Assets:    
Investments for deferred compensation plan 99 90
Level 1 | Deferred compensation | Common stock    
Assets:    
Investments for deferred compensation plan 974 540
Level 1 | Deferred compensation | Money market funds    
Assets:    
Investments for deferred compensation plan 7,009 7,359
Level 1 | Deferred compensation | Mutual funds    
Assets:    
Investments for deferred compensation plan 23,996 21,017
Level 2    
Assets:    
Cash equivalents 0 0
Investments for deferred compensation plan 0 0
Currency derivative assets 68 90
Liabilities:    
Currency derivative liabilities 5,924 2,849
Level 2 | Deferred compensation | Cash    
Assets:    
Investments for deferred compensation plan 0 0
Level 2 | Deferred compensation | Common stock    
Assets:    
Investments for deferred compensation plan 0 0
Level 2 | Deferred compensation | Money market funds    
Assets:    
Investments for deferred compensation plan 0 0
Level 2 | Deferred compensation | Mutual funds    
Assets:    
Investments for deferred compensation plan 0 0
Level 3    
Assets:    
Cash equivalents 0 0
Investments for deferred compensation plan 0 0
Currency derivative assets 0 0
Liabilities:    
Currency derivative liabilities 0 0
Level 3 | Deferred compensation | Cash    
Assets:    
Investments for deferred compensation plan 0 0
Level 3 | Deferred compensation | Common stock    
Assets:    
Investments for deferred compensation plan 0 0
Level 3 | Deferred compensation | Money market funds    
Assets:    
Investments for deferred compensation plan 0 0
Level 3 | Deferred compensation | Mutual funds    
Assets:    
Investments for deferred compensation plan $ 0 $ 0
v3.25.4
Fair Value Measurements - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity method investments $ 19,200,000   $ 19,200,000   $ 18,400,000
Impairment of non-marketable investments 0 $ 0 0 $ 0  
Equity investments included in other assets 8,800,000   8,800,000   8,800,000
Financial assets impairment charges   0   0  
Impairment of non-financial assets 0 $ 0 0 $ 0  
Level 1          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Investments in privately held companies $ 32,078,000   $ 32,078,000   $ 29,006,000
v3.25.4
Derivative Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
 9 Months Ended
Dec. 31, 2025
Mar. 31, 2025
Foreign exchange contract | Designated as hedging instruments    
Derivative [Line Items]    
Cash flow hedge loss to be reclassified within twelve months $ 8.3  
Foreign exchange contract | Designated as hedging instruments | Cash flow hedges    
Derivative [Line Items]    
Derivative, notional amount 444.5 $ 74.6
Foreign exchange forward and swap | Not designated as hedging instrument    
Derivative [Line Items]    
Derivative, notional amount $ 95.0 $ 131.8
Derivative term of contract 1 month  
v3.25.4
Derivative Financial Instruments - Schedule of Gains and Losses on Derivative Instruments (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Amounts of gains and losses on the derivative instruments        
Amount of Gain (Loss) Deferred as a Component of Accumulated Other Comprehensive Loss $ (5,047) $ 3,577 $ (16,807) $ 2,228
Amount of Loss Reclassified from Accumulated Other Comprehensive Loss to Costs of Goods Sold 3,328 790 11,291 (849)
Designated as hedging instruments | Cash flow hedges        
Amounts of gains and losses on the derivative instruments        
Amount of Gain (Loss) Deferred as a Component of Accumulated Other Comprehensive Loss (5,047) 3,577 (16,807) 2,228
Amount of Loss Reclassified from Accumulated Other Comprehensive Loss to Costs of Goods Sold $ 3,328 $ 790 $ 11,291 $ (849)
v3.25.4
Goodwill and Other Intangible Assets - Schedule of Activity In Goodwill Balance (Details)
$ in Thousands
 9 Months Ended
Dec. 31, 2025
USD ($)
Goodwill  
Balance at the beginning of the period $ 463,230
Effects of foreign currency translation 3,349
Balance at the end of the period $ 466,579
v3.25.4
Goodwill and Other Intangible Assets - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 209,886 $ 208,278
Accumulated Amortization (195,997) (183,648)
Net Carrying Amount 13,889 24,630
Effects of foreign currency translation, gross carrying amount 988 (620)
Effects of foreign currency translation, accumulated amortization (1,069) 137
Effects of foreign currency translation, net carrying amount (81) (483)
Trademarks and trade names    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 32,390 32,390
Accumulated Amortization (30,282) (28,675)
Net Carrying Amount 2,108 3,715
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 107,421 107,421
Accumulated Amortization (102,253) (96,464)
Net Carrying Amount 5,168 10,957
Customer contracts/relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 69,087 69,087
Accumulated Amortization (62,393) (58,646)
Net Carrying Amount $ 6,694 $ 10,441
v3.25.4
Financing Arrangements (Details)
Jan. 27, 2025
USD ($)
extension
Dec. 31, 2025
USD ($)
Mar. 31, 2025
USD ($)
Financing Arrangements      
Outstanding borrowings   $ 0 $ 0
Senior Unsecured Revolving Credit Facility | Line of credit      
Financing Arrangements      
Option to increase credit facility, additional amount $ 250,000,000    
Extension term 1 year    
Number of term extensions | extension 2    
Outstanding borrowings   0  
Senior Unsecured Revolving Credit Facility | Line of credit | Minimum      
Financing Arrangements      
Basis spread on variable rate 0.00%    
Senior Unsecured Revolving Credit Facility | Line of credit | Maximum      
Financing Arrangements      
Basis spread on variable rate 1.50%    
Line of credit      
Financing Arrangements      
Maximum borrowing capacity   164,000,000.0 172,200,000
Outstanding bank guarantees   $ 8,500,000 $ 12,100,000
Revolving Credit Facility | Senior Unsecured Revolving Credit Facility | Line of credit      
Financing Arrangements      
Maximum borrowing capacity $ 750,000,000    
Letter of Credit | Senior Unsecured Revolving Credit Facility | Line of credit      
Financing Arrangements      
Maximum borrowing capacity $ 100,000,000    
v3.25.4
Commitments and Contingencies - Schedule of Changes in Warranty Liabilities (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Changes in the warranty liability:        
Beginning of the period $ 50,191 $ 46,833 $ 49,184 $ 44,654
Provision 9,430 12,060 28,424 34,022
Settlements (8,438) (9,111) (27,079) (29,124)
Effects of foreign currency translation 260 (721) 914 (491)
End of the period $ 51,443 $ 49,061 $ 51,443 $ 49,061
v3.25.4
Commitments and Contingencies - Narrative (Details)
Dec. 31, 2025
USD ($)
Indemnification Agreement  
Other Commitments [Line Items]  
Amount accrued for indemnification provisions $ 0
v3.25.4
Shareholders' Equity - Narrative (Details)
SFr / shares in Units, $ / shares in Units, $ in Thousands, SFr in Millions
 1 Months Ended 9 Months Ended
Sep. 30, 2025
shares
Sep. 30, 2023
shares
Jun. 30, 2025
USD ($)
shares
Mar. 31, 2025
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2025
USD ($)
SFr / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
SFr / shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2025
CHF (SFr)
SFr / shares
shares
Mar. 31, 2025
SFr / shares
Mar. 31, 2025
USD ($)
shares
Class of Stock [Line Items]                        
Common stock outstanding           $ 28,001 $ 28,001     SFr 40.2   $ 29,432
Shares issued (in shares)           160,784,460 160,784,460     160,784,460   168,994,000
Shares, par value (in CHF per share) | SFr / shares                   SFr 0.25 SFr 0.25  
Treasury, at cost, shares (in shares)           14,026,614 14,026,614     14,026,614   20,485,000
Adjusted share capital period (in years) 5 years 5 years                    
Maximum percentage of shares held by the company and its subsidiaries           10.00% 10.00%     10.00%    
Maximum shares available for purchase (in shares)           16,100,000 16,100,000     16,100,000    
Shares acquired for cancellation (in shares)             1,100,000          
Shares acquired for equity incentive plans or potential acquisitions (in shares)             12,900,000          
Cash dividends per share declared (in dollars per share) | (per share)           $ 1.26 $ 1.58 SFr 1.16 $ 1.37      
Payment of cash dividends | $             $ 233,059   $ 207,853      
2023 Share Repurchase Program                        
Class of Stock [Line Items]                        
Period for which repurchase program will remain in effect (in years)         3 years              
Share repurchase, authorized amount (up to) | $         $ 1,000,000             $ 1,600,000
Increase in authorized amount under share repurchase program | $       $ 600,000                
Amount available for repurchase | $           $ 409,500 $ 409,500          
Cancellation of treasury shares (in shares)     8,200,000                  
Treasury shares repurchased | $     $ 712,200                  
Common Stock Capital Shares Reserved For Future Issuance Employee Equity Incentive Plans                        
Class of Stock [Line Items]                        
Shares that may be issued out of conditional capital (in shares)           25,000,000 25,000,000     25,000,000    
Common Stock Capital Shares Reserved For Future Issuance Conversion Rights Under Future Convertible Bond Issuance                        
Class of Stock [Line Items]                        
Shares that may be issued out of conditional capital (in shares)           25,000,000 25,000,000     25,000,000    
Minimum                        
Class of Stock [Line Items]                        
Number of adjusted share capital (in shares) 144,706,014 155,795,958                    
Maximum                        
Class of Stock [Line Items]                        
Number of adjusted share capital (in shares) 176,862,906 190,417,282                    
v3.25.4
Shareholders' Equity - Schedule of Shares Repurchased (Details) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Equity, Class of Treasury Stock [Line Items]        
Aggregate cost of shares repurchased $ 23,254 $ 199,283 $ 239,056 $ 461,402
2023 Share Repurchase Program        
Equity, Class of Treasury Stock [Line Items]        
Number of shares repurchased (in shares)     2,678 5,328
Aggregate cost of shares repurchased     $ 239,056 $ 461,402
Aggregate cost of shares repurchased but not yet paid     $ 2,400 $ 17,600
v3.25.4
Shareholders' Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period $ 2,083,013 $ 2,111,894 $ 2,127,420 $ 2,233,653
Other comprehensive income (loss) 369 (34,950) 20,827 (23,120)
End of the period 2,335,723 2,102,818 2,335,723 2,102,818
Total        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period (126,494) (99,372) (146,952) (111,202)
End of the period (126,125) $ (134,322) (126,125) $ (134,322)
Currency Translation Adjustment        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period     (118,652)  
Other comprehensive income (loss)     26,874  
End of the period (91,778)   (91,778)  
Defined Benefit Plans        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period     (25,276)  
Other comprehensive income (loss)     (531)  
End of the period (25,807)   (25,807)  
Deferred Hedging Losses        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period     (3,024)  
Other comprehensive income (loss)     (5,516)  
End of the period $ (8,540)   $ (8,540)  
v3.25.4
Segment Information - Schedule of Segment Revenue, Gross Profit, and Net Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]        
Net sales $ 1,421,479 $ 1,340,294 $ 3,755,238 $ 3,544,545
Less: Significant segment expenses        
Cost of goods sold 805,267 763,403 2,141,277 2,010,411
Marketing and selling 206,875 217,048 601,664 615,816
Research and development 78,452 77,973 229,149 229,485
General and administrative 41,921 42,117 125,520 123,748
Share-based compensation expense 23,435 26,193 86,575 76,067
Interest income (10,985) (12,176) (34,042) (42,603)
Provision for income taxes 48,091 45,061 108,946 101,202
Net income 251,039 200,147 567,724 487,463
Reportable Segment        
Segment Reporting Information [Line Items]        
Net sales 1,421,479 1,340,294 3,755,238 3,544,545
Less: Significant segment expenses        
Cost of goods sold 802,631 761,230 2,132,902 2,001,738
Marketing and selling 200,964 205,235 569,682 581,683
Research and development 73,057 72,930 211,737 213,636
General and administrative 32,428 34,953 96,714 106,336
Share-based compensation expense 23,435 26,193 86,575 76,067
Amortization of intangible assets and acquisition-related costs 2,488 5,087 11,283 15,409
Interest income (10,985) (12,176) (34,042) (42,603)
Other (1,669) 1,634 3,717 3,614
Provision for income taxes 48,091 45,061 108,946 101,202
Net income $ 251,039 $ 200,147 $ 567,724 $ 487,463
v3.25.4
Segment Information - Schedule of Net Sales by Product Categories, Excluding Intercompany Transactions (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]        
Net sales $ 1,421,479 $ 1,340,294 $ 3,755,238 $ 3,544,545
Gaming        
Segment Reporting Information [Line Items]        
Net sales 482,714 466,715 1,121,894 1,076,660
Keyboards & Combos        
Segment Reporting Information [Line Items]        
Net sales 254,612 236,748 712,974 662,017
Pointing Devices        
Segment Reporting Information [Line Items]        
Net sales 241,160 217,045 658,034 602,927
Video Collaboration        
Segment Reporting Information [Line Items]        
Net sales 193,252 176,053 527,645 482,755
Webcams        
Segment Reporting Information [Line Items]        
Net sales 82,268 84,419 249,944 237,572
Tablet Accessories        
Segment Reporting Information [Line Items]        
Net sales 93,567 77,433 269,855 241,586
Headsets        
Segment Reporting Information [Line Items]        
Net sales 45,939 45,886 134,959 137,038
Other        
Segment Reporting Information [Line Items]        
Net sales $ 27,967 $ 35,995 $ 79,933 $ 103,990
v3.25.4
Segment Information - Schedule of Net Sales and Long-Lived Assets by Geographic Region (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Net sales to unaffiliated customers and long-lived assets by geographic region          
Total Sales $ 1,421,479 $ 1,340,294 $ 3,755,238 $ 3,544,545  
Property, plant and equipment, net 173,320   173,320   $ 170,105
Americas          
Net sales to unaffiliated customers and long-lived assets by geographic region          
Total Sales 556,358 553,563 1,480,784 1,518,933  
Property, plant and equipment, net 60,604   60,604   61,521
EMEA          
Net sales to unaffiliated customers and long-lived assets by geographic region          
Total Sales 485,731 454,665 1,214,948 1,116,368  
Property, plant and equipment, net 50,494   50,494   47,874
Asia Pacific          
Net sales to unaffiliated customers and long-lived assets by geographic region          
Total Sales 379,390 $ 332,066 1,059,506 $ 909,244  
Property, plant and equipment, net $ 62,222   $ 62,222   $ 60,710
v3.25.4
Segment Information - Narrative (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
Mar. 31, 2025
USD ($)
Segment Reporting Information [Line Items]          
Number of operating segments (in segments) | segment     1    
Number of reportable segments (in segments) | segment     1    
Long lived assets $ 173,320   $ 173,320   $ 170,105
Switzerland          
Segment Reporting Information [Line Items]          
Long lived assets 26,100   26,100   24,100
United States          
Segment Reporting Information [Line Items]          
Long lived assets 59,100   59,100   60,000
China          
Segment Reporting Information [Line Items]          
Long lived assets $ 45,600   $ 45,600   $ 43,400
Geographic concentration | Consolidated net sales from continuing operations | Switzerland          
Segment Reporting Information [Line Items]          
Percentage of consolidated net sales 4.00% 3.00% 4.00% 3.00%